Author(s)

D. S. Deenadayal^*, D. Vidyasagar, Vyshanavi Bommakanti, Karuna Goel, Nabeelah Naeem

Department of Otolaryngology and Head and Neck Surgery, Yashoda Hospital, Secunderabad, India.

Objective: To assess the outcomes of hearing and vertigo in patients with Meniere’s disease who were treated with intratympanic methylprednisolone. Study Design: Retrospective study. Setting: Tertiary referral hospital. Methods: In our study with 151 patients [191 ears] were diagnosed as Menieres as per 1995 AAO-HNS guidelines. As an office based procedure these patients were treated with intratympanic methyl prednisolone. Results: There was a 98.6% improvement in the vertigo control rate, a 73.82% improvement in hearing and 29.31% had a definitive improvement in tinnitus. Conclusion: We conclude from our study that intratympanic steroid injection significantly controls vertigo, tinnitus and improves hearing in Meniere’s disease with minimal complications. Hence, it can be tried as a first line treatment for patients with Meniere’s disease.

Meniere’s, Intratympanic Steroids, Methyl Prednisolone

Deenadayal, D. , Vidyasagar, D. , Bommakanti, V. , Goel, K. and Naeem, N. (2016) Role of Intratympanic Steroids in the Management of Meniere’s Disease—A Review of 151 Cases. International Journal of Otolaryngology and Head & Neck Surgery, 5, 108-113. doi: 10.4236/ijohns.2016.52018.